Literature DB >> 30954647

Vulnerability of pediatric patients with mitochondrial disease to vaccine-preventable diseases.

Shannon K Kruk1, Susan E Pacheco2, Mary Kay Koenig2, Jenna R E Bergerson3, Eliza Gordon-Lipkin1, Peter J McGuire4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30954647      PMCID： PMC6733614          DOI： 10.1016/j.jaip.2019.03.046

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome.

Authors:  R K Naviaux; W L Nyhan; B A Barshop; J Poulton; D Markusic; N C Karpinski; R H Haas
Journal:  Ann Neurol       Date:  1999-01       Impact factor: 10.422

Review 2.  The emerging role of immune dysfunction in mitochondrial diseases as a paradigm for understanding immunometabolism.

Authors:  Senta M Kapnick; Susan E Pacheco; Peter J McGuire
Journal:  Metabolism       Date:  2017-11-21       Impact factor: 8.694

3.  Cause of Death in Children With Mitochondrial Diseases.

Authors:  Soyong Eom; Ha Neul Lee; Sunho Lee; Hoon-Chul Kang; Joon Soo Lee; Heung Dong Kim; Young-Mock Lee
Journal:  Pediatr Neurol       Date:  2016-10-13       Impact factor: 3.372

4.  Antibiotic Resistance of Potential Otopathogens Isolated From Nasopharyngeal Flora of Children With Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.

Authors:  Alexis Rybak; Corinne Levy; Stéphane Bonacorsi; Stéphane Béchet; François Vié le Sage; Annie Elbez; Emmanuelle Varon; Robert Cohen
Journal:  Pediatr Infect Dis J       Date:  2018-03       Impact factor: 2.129

5.  Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation.

Authors:  Tatyana N Tarasenko; Susan E Pacheco; Mary Kay Koenig; Julio Gomez-Rodriguez; Senta M Kapnick; Francisca Diaz; Patricia M Zerfas; Emanuele Barca; Jessica Sudderth; Ralph J DeBerardinis; Raul Covian; Robert S Balaban; Salvatore DiMauro; Peter J McGuire
Journal:  Cell Metab       Date:  2017-06-06       Impact factor: 27.287

6.  Diagnostic criteria for respiratory chain disorders in adults and children.

Authors:  F P Bernier; A Boneh; X Dennett; C W Chow; M A Cleary; D R Thorburn
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

7.  The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection.

Authors:  Joseph L Edmonds; Daniel J Kirse; Donald Kearns; Reena Deutsch; Liesbeth Spruijt; Robert K Naviaux
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-04

Review 8.  Mitochondrial disease: genetics and management.

Authors:  Yi Shiau Ng; Doug M Turnbull
Journal:  J Neurol       Date:  2015-08-28       Impact factor: 4.849

9.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Sarah Schillie; Claudia Vellozzi; Arthur Reingold; Aaron Harris; Penina Haber; John W Ward; Noele P Nelson
Journal:  MMWR Recomm Rep       Date:  2018-01-12
  9 in total
  3 in total

Review 1.  The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence.

Authors:  Allison Hanaford; Simon C Johnson
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

Review 2.  Mitochondrial Disorders.

Authors:  Thomas Klopstock; Claudia Priglinger; Ali Yilmaz; Cornelia Kornblum; Felix Distelmaier; Holger Prokisch
Journal:  Dtsch Arztebl Int       Date:  2021-11-05       Impact factor: 8.251

3.  Risk mitigation behaviors to prevent infection in the mitochondrial disease community during the COVID-19 pandemic.

Authors:  Eliza Gordon-Lipkin; Shannon Kruk; Elizabeth Thompson; Philip Yeske; Lori Martin; Michio Hirano; Bruce H Cohen; Christopher Steven Marcum; Peter J McGuire
Journal:  Mol Genet Metab Rep       Date:  2021-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.